In accordance with Schott’s findings[14] for patients with head and neck squamous cell carcinoma (HNSCC), we also found significantly elevated level of the CCR4 ligand, CCL22, in SSCC patients compared to healthy subjects. Here, CCL22 is linked to head and neck squamous cell carcinoma.